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CORRELATES BETWEEN ATTENTION-DEFICIT/HYPERACTIVITY DISORDER 
DIMENSIONAL BEHAVIORAL SCALES AND URINARY NEUROCHEMICAL 
EXCRETION. Benson P. Yang, John M. Holahan, George M. Anderson, and Bennett A. 
Shaywitz. Department of Pediatrics, Yale University, School of Medicine, New Haven, CT. 
Attention-deficit/hyperactivity disorder (ADHD) is a neurobiological condition characterized 
by inattention, impulsivity, and hyperactivity. This study of 251 boys attempts to establish 
biological correlates of the core features of ADHD through measurable differences in 
sympathoadrenomedullary function. Behavioral constructs based on recent DSM notions of 
ADHD were empirically derived from factor analysis of several assessment instruments. The 
constructs were examined as dimensional variables to determine whether certain behavioral 
profiles were predictive of catecholamine or cortisol excretion. Data from parents and 
teachers were analyzed separately to examine the relationship between informant source and 
urinary neurochemical levels. Bivariate analyses revealed that reduced urinary epinephrine 
excretion was significantly correlated with the DSM-IV-based inattention scale. These 
correlations were stronger when children were rated by teachers (r=-0.213, p=0.001) than 
when they were rated by parents (r=-0.145, p=0.022). Furthermore, significant negative 
correlations were found between the DSM-IV-based inattention scales and urinary 
norepinephrine excretion, but only for teacher-completed ratings (r=-0.177, p=0.005). 
Analysis using a multiple regression model reaffirmed the results found with bivariate 
correlations. Overall, measurements of neurochemical excretion support the construct 
validity of the DSM-IV characterization of ADHD which separates inattention and impulsivity 
over the DSM-III characterization which combines these constructs. 
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Chapter 1 
Introduction 
Attention-deficit/hyperactivity disorder (ADHD) is a persistent neurobiological 
condition that can have dramatic impact upon normal development and performance. Patients 
typically exhibit core problems in attentional regulation, impulse control, and activity 
modulation. Prevalence rates vary according to the population that is sampled and the 
definitions that are used to characterize the disorder; generally, estimates range between 3 and 
6 percent (Goldman et al., 1998), but as many as 10 to 20 percent of the school-age 
population may be affected (Shaywitz et al., 1988). The disorder has been found to exist in 
virtually every country in which it has been studied, though it is not always labeled ADHD 
or treated in the same fashion as in the United States. If left untreated, ADHD patients may 
be predisposed to psychiatric and social difficulties later in life. While ADHD has become 
increasingly recognized as a disorder, much controversy still surrounds its etiology, diagnosis, 
and treatment. 
The cause of ADHD is likely to be multifactorial, involving psychosocial, 
environmental, and biological influences. The undeniable success of stimulant medications 
in ameliorating restlessness and distractibility and in improving performance and productivity 
has focused research efforts on catecholaminergic abnormalities (Barkley, 1977; Evans et al., 
1991; Swanson et al., 1991). The hypothesis of central dopamine deficiency originated with 
the observation that adults with Economo’s encephalitis developed Parkinson’s disease while 
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children with the same condition developed'attentional and motor symptoms (Raskin et al, 
1984). Dopaminergic systems have been implicated in modulating activity levels (Barnes et 
al, 1987) as well as in mediating the response to stimuli (Quay, 1988). In addition, animal 
models of ADHD suggest increases in dopaminergic activity following the administration of 
dextroamphetamine (Shaywitz eta/., 1976) and methylphenidate (Shaywitz et al, 1978), the 
two major stimulant medications in use today. Other animal studies indicate that the 
destruction of dopaminergic pathways in the prefrontal cortex results in hyperactivity 
(Glowinski et al, 1984). However, pharmacological studies have yielded contradictory 
findngs with regard to the dopamine hypothesis. Dopamine agonists, such as 
carbidopa/levodopa, did not bring about improvements in children with ADHD (Langer et al, 
1982). Yet, dopamine antagonists, such as haloperidol, chlorpromazine, and thioridazine, 
were moderately effective (Winsberg et al, 1978). 
In brain, there are several distinct dopamine systems. The principal pathways, termed 
mesocortical and mesolimbic projections, link the ventral tegmental and substantia nigra 
dopamine cells with the neostriatum and various limbic structures. Abnormalities in the 
centra! dopaminergic systems have generally been investigated by measureing the 
concentrations of homovanillic acid (HVA), the major matabolite of dopamine, in the urine 
and CSF. Several studies have failed to find differences in urinary HVA levels between 
ADHD and control groups (Wender et al, 1971; Shekim et al, 1983). Likewise, no 
difference in CSF HVA was found between ADHD and control subjects (Shetty et al, 1976). 
However, studies using probenecid, an agent that blocks the active transport of HVA, have 
indicated that dopamine turnover might be dimished in ADHD (Shaywitz et al, 1977). As 

3 
yet, there is not sufficient evidence to conclude that central dopaminergic systems are 
primarily involved in the etiology of ADHD. 
Although they seem to have their predominant effects on the central dopaminergic 
systems, the major stimulant medications are known to affect other neurotransmitter systems 
which may lead to clinically observed symptoms of ADHD (Braestrup, 1977; Elia et al., 
1990). Animal studies have suggested that norepinephrine depletion in brain produces 
attentional deficits (Mason et al., 1978; Maas et al., 1983). Studies of central noradrenergic 
function in humans have mostly focused on urinary measurements of 3-methoxy-4- 
hydroxyphenylglycol (MHPG), the main metabolite of norepinephrine. However, results have 
varied dramatically (Wender et al., 1971; Khan et al., 1981; Shekim et al., 1983). These 
inconsistencies may be due to the fact that peripheral MHPG levels only partially reflect 
central processes (Elsworth etal, 1984). Another complication involves uncertainty over the 
period of time that constitutes an adequate washout period, after which catecholamine 
measurements are not significantly tainted by the effects of medication. Pharmacological 
studies have shown that administration of desipramine, a tricyclic antidepressant, resulted in 
decreases in both plasma and urinary MHPG; these decreases were correlated with 
improvements in activity level (Donnelly et al., 1986). Published results concerning 
noradrenergic involvement remain too contradictory to support any solid interpretations, 
though findings do suggest an important role of norepinephrine in the pathophysiology of 
ADHD. 
Although measurements with norepinephrine have yielded inconsistent results, several 
pharmacological studies indicate that stimulants seem to increase urinary epinephrine levels 
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(Donnelly et al., 1989; Elia et al., 1990; McCracken et al., 1990). In fact, the only common 
biological effect between methylphenidate and dextroamphetamine appears to be increased 
epinephrine excretion (Elia et al., 1990). In examining the urinary norepinephrine to 
epinephrine ratio, a higher proportion of epinephrine was found to correlate positively with 
measures of attention (Tennes et al., 1986). Lower urinary epinephrine levels were detected 
in ADHD children relative to normal controls (Klinteberg et al., 1989). Another study found 
that children with increases in urinary epinephrine levels during a stressor situation performed 
better in several tests of attention, whereas those who showed decreases in epinephrine 
excretion performed worse on the same tests (Elwood et al., 1986). Glucose injection 
experiments show that ADHD children may have blunted catecholamine responses to stress 
(Girardi et al, 1995). Although the bulk of ADHD research has focused on more direct 
measures of central catecholamine function, these findings suggest that epinephrine may be 
an important marker as well. 
Several theories have been proposed in recent years attempting to consolidate the 
array of neurochemical findings. It has been argued that an imbalance in epinephrine system 
in the brainstem may lead to disruption of attentional systems in higher cognitive centers 
(Mefford et al., 1989). This model suggests that symptoms of ADHD are a result of 
increased firing of the norepinephrine-rich locus ceruleus. In turn, peripheral adrenergic 
systems may also be dysfunctional and hence feed back upon central attentional systems 
inappropriately (McCracken, 1991). Thus, stimulant-induced increases in peripheral 
epinephrine levels may lead to improvements in ADHD symptoms. In support of this 
hypothesis, epinephrine and norepinephrine excretion were found to be positively correlated 
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with good teacher ratings for social adjustment and emotional stability (Johansson et al., 
1973). A more recent model postulates that ADHD symptoms may result from partial 
denervation of postjunctional a2-receptors in the prefrontal cortex (Arnsten et al., 1996). 
According to this view, pharmacological treatments alleviate symptoms by stimulating these 
a2-receptors. 
The present study expands upon an earlier analysis of the same sample population, the 
largest ADHD study cohort to date (Dover, 1998). That study examined 
sympathoadrenomedullary function in children who have been categorized according to DSM- 
IV (American Psychiatric Association, 1994) criteria for ADHD. No group diagnostic 
differences were found for urinary norepinephrine excretion, but a significant main effect of 
ADHD status was found for urinary epinephrine excretion. Lower urinary epinephrine levels 
were found across the combined ADHD subtypes examined. The present study examines 
sympathoadrenomedullary function with respect to dimensional behavioral constructs, 
specifically those chosen to emulate DSM-III (American Psychiatric Association, 1980) and 
DSM-IV criteria. This approach bypasses many of the controversial definitional issues by 
creating relatively pure scales. Furthermore, multiple instruments completed by both parents 
and teachers are employed in scale development. 
1.1 STATEMENT OF PURPOSE 
Previous research on the neurochemical systems have examined levels of 
catecholamines and their metabolites in cerebrospinal fluid, plasma, and urine (Zametkin et 
al., 1987). However, the study samples have been too small to warrant confident 
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conclusions. Furthermore, findings have been difficult to interpret due to a lack of standard 
measurement protocols and disagreement over the definition of ADHD. A scientifically 
validated system of classfication for ADHD is a prerequisite not only for further research, but 
for meaningful communication among those who work with children afflicted by the disorder. 
This study attempts to elucidate the relationships that may exist between urinary' 
catecholamine and urinary cortisol levels and various behavioral manifestations of ADHD 
Assessment data from parents and teachers were analyzed separately to examine the 
relationship between informant source and urinary neurochemical levels. Behavioral 
constructs were empirically derived, based on recent DSM notions of ADHD, but were 
examined as dimensional variables to determine whether certain behavioral profiles were 
predictive of catecholamine or cortisol excretion. Biological validation of the core features 
of ADHD, through measureable differences in sympathoadrenomedullary function, will aid 
in the understanding, description, and diagnosis of the disorder. 
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Chapter 2 
Background 
2.1 Core Features of ADHD 
Despite various definitional changes throughout the years, the three core features of 
ADHD have remained fairly stable. The primary symptoms of ADHD are inattention, 
impulsivity, and hyperactivity. Some evidence has demonstrated that the attentional deficits 
in ADHD are primarily those related to hypervigilance or lack of sustained attention 
(Douglas, 1983). A person exhibiting this type of inattention will show decreased 
performance in tests with prolonged and repetitive stimuli. In the real world, the person may 
pay attention to many different things in the environment at the same time and may have great 
difficulty focusing or maintaining attention on one thing over a sustained period of time. 
Factor analytic studies have not shown impulsivity to be an isolated dimension (Bauermeister 
etal., 1992). Cognitive impulsivity, characterized by a child’s need for supervision and lack 
of organization, loads together with inattention. On the other hand, behavioral impulsivity, 
characterized by a child’s failure to consider consequences before acting and blurting out, 
loads together with hyperactivity. Youngsters with ADHD display greater amounts of motor 
activity than comparison children at all times of the day, including sleep (Porrino et al., 1983). 
In the classroom, these children may frequently leave their seats or constantly fidget in their 
chairs. Interestingly, studies have found hyperactivity and impulsivity to be more specific than 
inattention in identifying ADHD patients (Halperin et al., 1992). In addition to these three 
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most common areas of difficulty, children with ADHD may have impairments in other areas 
of psychological functioning, including working memory, affect regulation, and problem¬ 
solving ability. 
2.2 Diagnosis of ADHD 
The diagnosis of ADHD is a clinical diagnosis. Recent changes in diagnostic criteria 
result from empirical research findings and expert committee consensus. The first empirically 
based official set of diagnostic criteria for what is now referred to as ADHD was delineated 
in DSM-III in 1980 (Table 1). The diagnosis of attention deficit disorder (ADD) was 
characterized primarily by high levels of inattention and impulsivity, with or without 
accompanying hyperactivity. This formulation is essentially dichotomous, with 
inattention/impulsivity and hyperactivity representing the symptom categories. In DSM-III-R 
(American Psychiatric Association, 1987), attention-deficit hyperactivity disorder (ADHD) 
was defined according to a single heterogeneous list that included symptoms of inattention, 
impulsivity, and hyperactivity. The assumption was that the disorder can be identified 
according to a more general scheme of maladaptive behavior. Later, factor analytic 
investigations indicated that inattention represents a fundamentally distinct dimension from 
behavioral impulsivity/hyperactivity (Lahey et al., 1988). The current DSM-IV classification 
of the disorder allows subtyping as predominantly inattentive type, predominantly 
hyperactive-impulsive type, or combined type (Table 2). This formulation is again 
dichotomous, this time with inattention and hyperactivity/impulsivity representing the 
symptom categories. The diagnosis of ADHD is based upon a clinical picture that begins in 
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Table 1. DSM-ITI diagnostic criteria for attention deficit disorder (American Psychiatric Association, 1980). 
Diagnostic criteria for Attention Deficit Disorder with Hyperactivity 
The child displays, for his or her mental and chronological age, signs of developmentally inappropriate inattention, 
impulsivity, and hyperactivity. The signs must be reported by adults in the child's environment, such as parents and 
teachers. Because the symptoms are typically variable, they may not be observed directly by the clinician. When the 
reports of teachers and parents conflict, primary consideration should be given to the teacher reports because of greater 
familiarity with age-appropriate norms. Symptoms typically worsen in situations that require self-application, as in the 
classroom. Signs of the disorder may be absent when the child is in a new or a one-to-one situation 
The number of symptoms specified is for children between the ages of eight and ten, the peak age range for referral. In 
younger children, more severe forms of the symptoms and a greater number of symptoms are usually present The 
opposite is true for older children. 
A Inattention. At least three of the following: 
(1) often fails to finish things he or she starts 
(2) often doesn't seem to listen 
(3) easily distracted 
(4) has difficulty concentrating on schoolwork or other tasks requinng sustained attention 
(5) has difficulty sticking to a play activity 
B. Impulsivity. At least three of the following: 
(1) often acts before thinking 
(2) shifts excessively from one activity to another 
(3) has difficulty organizing work (this not being due to cognitive impairment) 
(4) needs a lot of supervision 
(5) frequently calls out in class 
(6) has difficulty awaiting turn in games or group situations 
C. Hyperactivity. At least two of the following: 
(1) runs about or climbs on things excessively 
(2) has difficulty’ sitting still or fidgets excessively 
(3) has difficulty staying seated 
(4) moves about excessively during sleep 
(5) is always "on the go" or acts as if "driven by a motor" 
D. Onset before the age of seven. 
E. Duration of at least six months. 
F. Not due to Schizophrenia, Affective Disorder, or Severe or Profound Mental Retardation. 
Diagnostic criteria for Attention Deficit Disorder without Hyperactivity 
The criteria for this disorder are the same as those for Attention Deficit Disorder with Hyperactivity except that the 
individual never had signs of hyperactivity (criterion C). 
Diagnostic criteria for Attention Deficit Disorder, Residual Type 
A. The individual once met the criteria for Attention Deficit Disorder with Hyperactivity. This information may come 
from the individual or from others, such as family members. 
B. Signs of hyperactivity are no longer present, but other signs of the illness have persisted to the present without periods 
.of remission, as evidenced by signs of both attentional deficits and impulsivity (e g , difficulty organizing work and 
completing tasks, difficulty concentrating, being easily distracted, making sudden decisions without thought of the 
consequences). 
C. The symptoms of inattention and impulsivity result in some impairment in social or occupational functioning. 
D. Not due to Schizophrenia, Affective Disorder, Severe or Profound Mental Retardation, or Schizotypal or Borderline 
Personality Disorders. 
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Table 2. DSM-IV diagnostic criteria for attention-deficit/hyperactivity disorder (American Psychiatric Association, 1994) 
Diagnostic criteria for Attention-Deficit/Hyperactivity Disorder 
A. Either (1) or (2): 
(1) six (or more) of the following symptoms of inattention have persisted for at least 6 months to a degree that is 
maladaptive and inconsistent with developmental level: 
Inattention 
(a) often fails to give close attention to details or makes careless mistakes in schoolwork, work, or other activities 
(b) often has difficulty sustaining attention in tasks or play activities 
(c) often does not seem to listen when spoken to directly 
(d) often does not follow through on instructions and fails to finish schoolwork, chores, or duties in the workplace (not 
due to oppositional behavior or failure to understand instructions) 
(e) often has difficulty organizing tasks and activities 
(f) often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort (such as schoolwork or 
homework) 
(g) often loses things necessary for tasks or activities (e g., toys, school assignments, pencils, books, or tools) 
(h) is often easily distracted by extraneous stimuli 
(i) is often forgetful in daily activities 
(2) six (or more) of the following symptoms of hyperactivity-inipulsivity have persisted for at least 6 months to a degree 
that is maladaptive and inconsistent with developmental level: 
Hyperactivity 
(a) often fidgets with hands or feet or squirms in seat 
(b) often leaves seat in classroom or in other situations in which remaining seated is expected 
(c) often runs about or climbs excessively in situations in which it is inappropriate (in adolescents or adults, may be 
limited to subjective feelings of restlessness) 
(d) often has difficulty playing or engaging in leisure activities quietly 
(e) is often "on the go" or often acts as if "driven by a motor" 
(f) often talks excessively 
Impulsivity 
(g) often blurts out answers before questions have been completed 
(h) often has difficulty awaiting turn 
(i) often interrupts or intrudes on others (e g., butts into conversations or games) 
B Some hyperactive-impulsive or inattentive symptoms that caused impairment were present before age 7 years. 
C. Some impairment from the symptoms is present in two or more settings (e g., at school [or work] and at home). 
D There must be clear evidence of clinically significant impairment in social, academic, or occupational functioning 
E. The symptoms do not occur exclusively during the course of a Pervasive Developmental Disorder, Schizophrenia, or other 
Psychotic Disorder and are not better accounted for by another mental disorder (e.g.. Mood Disorder, Anxiety Disorder, 
Dissociative Disorder, or a Personality Disorder). 
Code based on type: 
314.01 Attention-Deficit/Hyperacrivity Disorder, Combined Type: if both Criteria A1 and A2 are met for the past 6 
months 
314.00 Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type: if Criterion A1 is met but 
Criterion A2 is not met for the past 6 months 
314.01 Attention-Deficit/Hyperactivity Disorder, Predominantly Hyperactive-Impulsive Type: if Criterion A2 is 
met but Criterion A1 is not met for the past 6 months 
Coding note: For individuals (especially adolescents and adults) who currently have symptoms that no longer meet full 
criteria, "In Partial Remission" should be specified. 
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childhood, is persistent over time, is pervasive across settings, and causes function 
impairment. As yet, there are no laboratory tests or measures that can be used to make a 
definitive diagnosis (Barkley, 1990). 
2.3 Categorical vs. Dimensional Perspectives 
A critical question in ADHD research concerns whether the core symptoms of the 
disorder should be interpreted as continua of function or grouped into discrete categories. 
Categorical models assume that disordered individuals who exhibit extremes of behavior differ 
qualitatively from those who are normal. Definitive cutoff points isolate these fundamentally 
distinct groups. Dimensional models assume that disordered individuals differ in degree, but 
not in kind. Hence, no cutoff points exist; everyone exhibits some amount of the trait in 
question and the only distinguishing factor is the magnitude of expression of that trait. As an 
example, the distribution of IQ scores forms a continuous curve that does not seem to have 
any natural cutoff points. But individuals with IQ scores below 45 have traditionally been 
classified as profoundly or severely retarded. In fact, this group does display a greater 
prevalence than would be predicted from a strictly normal distribution and known genetic 
defects have been identified in this population (Rutter et al., 1990). A categorical approach 
that applies cutoff points to this distribution seems to be superior in this case In another 
study, retrospectively recalled symptoms of conduct disorder (CD) were used to predict 
young adult substance abuse (Robins et al, 1991). The number of child symptoms recalled 
was linearly related to later substance abuse; the threshold for a diagnosis of CD did not 
create a discontinuity in predictive power. Here, the dimensional model seems to be superior. 
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As demonstrated by the first example, failure to recognize underlying classes may obscure 
substantial qualitative differences. But unless discrete groups are clearly validated, where 
significant discontinuities between classes exist, categorical models may create artificial 
boundaries that hinder understanding and diminish statistical power. 
Research in this area with regard to ADHD has been relatively sparse, probably 
because of the difficulty associated with assessing behavioral traits. One study demonstrated 
that dimensionally scored representations of symptom measures had consistently better 
predictive validity than measures based on the categorically defined DSM-III-R criteria 
(Fergusson et ai, 1995). Another genetics study based on DSM-III-R suggests that ADHD 
may represent the tail of a continuum that varies genetically across the entire population and 
not as a disorder with discrete determinants (Levy et a/., 1997). Another study suggests that 
it may be more informative if ADHD is considered as a composite of two continuously 
distributed dimensions rather than as one homogeneous categorical disorder of DSM-III-R 
(Sherman et a/., 1997). Whether subtyping ADHD into more finely defined groups, as in 
DSM-III and DSM-IV, represents a better conceptualization than the continuous 
bidimensional model remains to be seen. At present, there does not appear to be any firm 
indication that categorization of ADHD or any of its behavioral constructs is superior to 
dimensionalization of those variables. 
2.4 Peripheral vs. Central Catecholamine Function 
Ethical considerations with respect to obtaining cerebrospinal fluid samples in children 
have forced researchers to rely on peripheral measures of neurotransmitter function 
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However, peripheral measurements of monoamines reflect only peripheral sources and 
peripheral measurements of monoamine metabolites reflect both central and peripheral 
sources. Although catecholamines cannot cross the blood-brain barrer, there is mounting 
evidence that central and peripheral noradrenergic systems are significantly correlated (Pliszka 
et ci/., 1996). Centrally, noradrenergic neurons of the locus ceruleus have been found to be 
involved in attentional processes (Aston-Jones e/a/., 1990). Peripherally, adrenergic neurons 
are found in the adrenal medulla and noradrenergic neurons are found throughout the 
sympathetic nervous system, which has its origin in the intermediolateral cell column of the 
spinal cord. The production and release of dopamine occurs in the adrenal medulla as well 
as in other organs. Neurons from the locus ceruleus make extensive projections to cortical 
and subcortical areas, but they do not impinge on the intermediolateral cell column (Holets, 
1990). While these systems seem to function independently, various stimuli have been found 
to activate them simultaneously (Elam et al., 1986). Indeed, the central noradrenergic system 
can be viewed as focusing mental energies while the peripheral sympathetic system can be 
seen as channeling physical resources in response to a stressor (Aston-Jones et al., 1991). 
Several studies on depression have relied on peripheral measures and concluded that urinary 
catecholamine excretion rates provide reliable and useful information (Linnoila et al., 1982; 
Koslow et al., 1983). Furthermore, infusion experiments have demonstrated that urinary free 
epinephrine and norepinephrine levels, as opposed to concentrations of their excreted 
metabolites, are the most sensitive indicators of circulating epinephrine and norepinephrine 
levels, respectively (Moleman et al., 1992). 
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Chapter 3 
Methods 
3.1 Subjects 
The subjects included 200 boys who were referred over a period of five years to the 
Yale University Center for Learning and Attention. They were enlisted by local media 
announcements or identified by schools, parent groups, and professionals for evaluation of 
attentional or learning problems In addition, 51 boys without attentional or learning 
problems were recruited over the same period by means of newspaper advertisements, letters 
to schools, and fliers in toy stores and libraries. A global telephone screen supplemented by 
diagnostic assessments assured that subjects satisfied the following criteria. Subjects must 
(1) be between 7.0 and 13.5 years old (2) not have a history of severe emotional problems 
or neurological disorders (3) have a Full Scale IQ score greater than or equal to 80 on the 
Wechsler Intelligence Scale for Children-Revised (WISC-R, Wechsler, 1974) (4) use English 
as their primary language (5) have normal or corrected vision and hearing (6) not have any 
siblings in the sample and (7) either not have a history of stimulant medications or be 
abstinent from stimulant medications for at least one month prior to testing. 
3.2 Diagnostic and Assessment Instruments 
Parents, usually the mother, completed the Swanson, Nolan, and Pelham Checklist 
(SNAP, Pelham eta/., 1984), the Yale Children’s Inventory (YCI, Shaywitz et al., 1986), and 
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the Diagnostic Interview Schodule for Children Version 2.3 (DISC-2.3, Shaffer et al., 1996). 
Regular classroom and, when involved, special education teachers completed the SNAP 
Checklist and the Multigrade Inventory for Teachers (MIT, Agronin et al., 1992). The SNAP 
contains 33 questions, each rated on a 4-point scale, that describe the core symptoms of 
overactivity, inattention, and impulsivity, as well as aggressive behavior toward other 
students. The version of the SNAP that was administered to the subjects reflects the DSM-III 
conceptualization of attention-deficit disorder. The YCI is a parent-rated instrument 
developed to assist clinicians and researchers in assessing children referred for learning and 
attentional problems. The 64 questions, each rated on a 4-point scale, are divided into 11 
narrow-band scales: inattention, hyperactivity, impulsivity, habituation, tractability, conduct 
disorder-socialized, conduct disorder-aggressive, negative affect, fine motor-adaptive, fine 
motor-academic, and language. The DISC-2.3 is a parent-rated structured interview that is 
designed to assess the child’s psychiatric diagnostic status. The 24 item checklist is derived 
from the DSM-IV conceptualization of attention-deficit/hyperactivity disorder. The MIT is 
a teacher-rated instrument designed to assess academic, attentional, and behavioral problems 
affecting the school-age child. The 56 questions, each rated on a 6-point scale, are divided 
into 6 narrow-band scales: academic, language, dexterity, attention, activity, and behavior. 
3.3 Laboratory Procedures 
Cognitive testing 
The evaluation consisted of four 4-hour sessions, each running from 8:30 am to 12:30 
pm over four days. The first session was a screening session where subjects underwent ability 

16 
and achievement testing. During the second and third sessions, subjects were given a variety 
of attention, language, visual motor, visual perception, and neuromaturation tests The EEG 
was administered during the final session followed by the Posner task. 
Sample collection 
Urine samples were collected during the second session of testing, after subjects have 
been acquainted with the testing protocol. Subjects were instructed to void prior to testing 
and encouraged to drink several glasses of water or apple juice during the testing period. In 
the event of test interference or insufficient urine volume, urine was collected again on the 
third day of testing. These samples were maintained separate from those collected on the 
second day of testing. Total urine volume was measured and 5 ml was aliquoted to storage 
vials containing 33 pi of 5% sodium metabisulfate, 33 pi ofEDTA, and 20 pi of glacial acetic 
acid (Anderson et al., 1988). Of this volume, 3 ml was separated and treated with 6 pi of 100 
ng/pl dihydroxybenzylamine (Aldrich) to give a concentration of 200 ng/ml of the internal 
standard. An additional 20 pi of sodium metabisulfate was added for neurochemical 
measurements. Samples were stored at -70 °C. 
Biochemical analysis 
Urinary norepinephrine, epinephrine, and dopamine concentrations were measured 
using high pressure liquid chromatography fluorometry (Anderson et al., 1988). Briefly, urine 
samples were thawed and adjusted to pH 8 4-8.7 using 3 M pH 8.7 TRIS buffer. The samples 
were mixed with 50 mg alumina for 10 minutes on a rotary mixer and centrifuged. After 
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washing the pellet twice with distilled water, 250 pi of 1 M acetic acid was added to elute the 
catecholamines. The eluant was removed and stored in 1.5 ml polypropylene tubes for HPLC 
analysis. Twenty to 50 pi of each eluant sample was injected into the chormoatographic 
system at a flow rate of 2.0 ml/min. For fluorometric detection, the excitation wavelength 
was 285 nm and the emission wavelength was 305 nm. Concentrations of each catecholamine 
were calculated based on the known concentration of DHBA (200 ng/ml). 
Urinary cortisol concentrations were measured using coated-tube radioimmunoassay 
kits (Diagnostic Systems Laboratory). Observed excretion rates were adjusted for body 
surface adjustments using Mosteller’s equation (Briars et al., 1994). 
3.4 Statistical Analysis 
Factor analysis 
The SNAP Checklist was subject to factor analysis for identification of questionnaire 
items which tapped into behavioral constructs, particularly those which pertained to the 
DSM-III conceptualization of ADD or the DSM-IV conceptualization of ADHD. Data from 
the entire sample population, consisting of 649 boys, and girls with and without medication 
histories, were incorporated into these analyses. Parent-completed questionnaires were 
examined separately from teacher-completed questionnaires. The method of principal 
components analysis (PCA) was chosen, with unity in the diagonal. Factors with eigenvalues 
above 1.0 were extracted (Kaiser, 1960). Rotation followed Kaiser’s varimax criterion which 
maximizes the variance of loading on one component and minimizes the variances of loadings 
on all other components (Kaiser, 1958). Retention or elimination of each individual item was 
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based on the magnitude of its factor loading and on simple structure (Thurstone, 1947). 
“Complex” items that had substantial loadings on two or more factors were eliminated 
because they simultaneously reflected two or more dimensions as defined by the factors. In 
short, an item was retained if it loaded substantially (0.5 or above) on one factor and not on 
any other factor. Since the factor structures of the YCI, the DISC-2.3, and the MIT are 
satisfactory, these instruments were not subject to factor analysis A factor scale, defined as 
the average of a factor’s constituent item scores, was calculated for each of the identified 
factors. All factor scales were standardized (to a mean of 0 and a standard deviation of 1) to 
facilitate comparison between individual instruments. 
Construction of composite factor scales 
In addition to the individual factor scales described above, parent-rated and teacher¬ 
rated composite scales were created to emulate the symptom categories described under the 
DSM-III conceptualization of ADD or the DSM-IV conceptualization of ADHD (Table 3) 
Following DSM-III, a composite scale for inattention/impulsivity and a composite scale for 
hyperactivity were created. Following DSM-IV, a composite scale for inattention and a 
composite scale for hyperactivity/impulsivity were created. Composite scales were 
constructed by averaging the standardized factor scale scores of those factors, from any ot 
the instruments used, which were most relevant to the symptom category. In certain 
instances, this calculation was a two-stage process whereby “sub-composite scales” were first 
constructed for the individual instruments; these scale scores were then used in the 
construction of the composite scale. For example, in the construction of the parent DSM-III- 
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Table 3. Composite scales constructed from individual instruments. 
Composite Scale Instruments used Factors used 
Parent DSM-I1I emulation 
Inattention/impulsivity factor-analyzed SNAP inattention/impulsivity 
YCI attention 
impulsivity 
DISC-2.3 inattention/impulsivity 
Hyperactivity factor-analyzed SNAP hyperactivity 
YCI activity' 
DISC-2.3 hyperactivity 
Teacher DSM-1II emulation 
Hyperactivity factor-analyzed SNAP hyperactivity 
MIT activity 
Parent DSM-IV emulation 
Inattention factor-analyzed SNAP inattention 
YCI attention 
DISC-2.3 inattention 
Hyperactivity/impulsivity factor-analyzed SNAP hyperactivity/impulsivity 
YCI activity 
impulsivity 
DISC-2.3 hyperactivity/impulsivity 
Teacher DSM-IV emulation 
Inattention factor-analyzed SNAP inattention 
MIT attention 
Hyperactivity/impulsivity factor-analyzed SNAP hyperactivity/impulsivity 
MIT activity 
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based composite scale for inattention/impulsivity, the three parent questionnaires were used 
With regard to the YCI, a “sub-composite scale” was constructed by averaging the 
standardized factor scale scores for inattention and impulsivity. These scale scores were then 
averaged with the factor-analyzed SNAP standardized factor scale scores for 
inattention/impulsivity and the DISC-2.3 standardized factor scale scores for 
inattention/impulsivity. Hence, the composite scale is an approximation of a behavioral 
construct that incorporates information from all the relevant instruments that were 
administered. Since neither the SNAP nor the MIT yield an inattention/impulsivity factor, a 
teacher DSM-HI-based composite scale for inattention/impulsivity could not be constructed 
Cross-Informant Ratings 
Pearson product-moment correlations were used to examine relationships among the 
composite and individual factor scales with respect to different informants, namely parents 
and teachers. Only a subset of the entire data set, consisting of 251 boys without recent 
medication histories, was used in this and subsequent analyses. High correlations between 
parent-rated scales and teacher-rated scales would support a single analysis which would 
include both parents and teachers. Low correlations between parent-rated scales and teacher¬ 
rated scales would support separate analyses, according to informant. 
Bivariate Analyses 
Pearson product-moment correlations were calculated to examine relationships between the 
factor scales and urinary catecholamine and urinary cortisol levels. 
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Multiple Regression Model 
A linear multiple regression model was used to examine the ability of the factor scales 
to predict each urinary catecholamine or urinary cortisol level. This is a more powerful 
approach than simple correlation analyses in that it takes account of multiple variables in the 
estimation of catecholamine excretion. According to DSM-III criteria, terms for the linear 
model were inattention/impulsivity, hyperactivity, and their interaction. According to DSM- 
IV criteria, terms for the linear model were inattention, hyperactivity/impulsivity, and their 
interaction. The multivariate approach attempts to examine the two behavioral constructs and 
their interaction in relation to a single neurochemical. 
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Chapter 4 
Results 
4.1 Factor Analysis 
Factor analysis of the parent-completed SNAP yielded three factors with eigenvalues 
greater than 1.0 (Table 4). The factors have been labeled as inattention/impulsivity, 
hyperactivity, and peer problems based on their item composition. These three factors 
accounted for 65% of the total variance. Factor analysis of the teacher-completed SNAP 
yielded similar results (Table 5). The three factors accounted for 72% of the total variance 
Parent and teacher factor scales for inattention/impulsivity and hyperactivity were created by 
averaging the item scores under the respective factors. Several items under the standard 
SNAP Impulsivity category factored with items under the standard SNAP Inattention 
category; other items under the standard SNAP Impulsivity category failed to factor 
significantly with any of the three factors. 
To simulate DSM-IV symptom categories, the standard SNAP Peer Problems items 
were omitted from factor analysis. A two factor solution was calculated to force the standard 
SNAP Impulsivity items into one or the other factor. For the parent-completed SNAP, these 
two factors accounted for 66% of the total variance (Table 6, Figure 1). For the teacher- 
completed SNAP, these two factors accounted for 71% of the total variance (Table 7, Figure 
2). The factors have been labeled as inattention and hyperactivity/impulsivity based on their 
item composition. Parent and teacher factor scales for inattention and 

Table 4. Varimax rotated factors matrix for parent-completed SNAP, DSM-III emulation. 
Eigenvalues 
Non-Rotated Variance Percentage 
I 
9.274 
46.372 
Factor 
II 
1.649 
8.244 
III 
2.012 
10.062 
I. Inattention/impulsivity 
Difficulty concentrating on school work or other tasks 
requiring sustained attention 0.833 0.198 0.156 
Difficulty' organizing work (not due to cognitive impairment) 0.826 0.059 0.116 
Often fails to finish things he or she starts 0.789 0.183 0.195 
Easily distracted 0.782 0.328 0.199 
Often doesn't seem to listen 0.712 0.327 0.281 
Needs a lot of supervision 0.709 0.207 0.282 
Often acts before thinking 0.557 0.373 0.388 
Difficulty sticking to a play activity 0.518 0.337 0.336 
II. Hyperactivity 
Always on the go or acts as if "driven by a motor" 0.221 0.828 0.191 
Difficulty staying seated 0.314 0.806 0.238 
Excessive running or climbing 0.155 0.805 0.162 
Difficulty sitting still or excessive fidgeting 0.331 0.802 0.189 
III. Peer problems 
Teases or calls other children names 0.119 0.159 0.771 
Frequently interrupts other children's activities 0.254 0.262 0.756 
Fights, hits, punches, etc. 0.066 0.281 0.712 
Bossy; always telling other children what to do 0.103 0.186 0.706 
Is disliked by other children 0.260 0.065 0.686 
Loses temper often and easily 0.273 0.249 0.633 
Difficulty waiting for turn in games or group situations 0.285 0.461 0.586 
Refuses to participate in group activities 0.261 -0.084 0.538 
'Based on entire sample: 649 boys and girls, with and without recent medication histones 
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Table 5. Varimax rotated factors matrix for teacher-completed SNAP, DSM-HI emulation.a 
Eigenvalues 
Non-Rotated Variance Percentage 
I 
7.998 
49.988 
Factor 
II 
1.311 
8.194 
III 
2.261 
14.130 
I. Inattention/impulsivity 
Difficulty concentrating on school work or other tasks 
requiring sustained attention 0.868 0.265 0.115 
Often fails to finish things he or she starts 0.855 0.108 0.111 
Difficulty organizing work (not due to cognitive impairment) 0.811 0.195 0.084 
Easily distracted 0.765 0.385 0.237 
Often doesn't seem to listen 0.760 0.280 0.213 
Needs a lot of supervision 0.696 0.329 0.312 
II. Hyperactivity 
Motor restlessness 0.303 0.825 0.197 
Difficulty sitting still or excessive fidgeting 0.366 0.824 0.211 
Always on the go or acts as if "driven by a motor" 0.192 0.802 0.269 
Difficulty staying seated 0.333 0.793 0.241 
HI. Peer problems 
Teases or calls other children names 0.126 0.194 0.797 
Bossy; always telling other children what to do 0.049 0.238 0.783 
Fights, hits, punches, etc. 0.119 0.145 0.756 
Is disliked by other children 0.228 0.076 0.748 
Loses temper often and easily 0.140 0.148 0.743 
Frequently interrupts other children's activities 0.309 0.441 0.637 
Based on entire sample: 649 boys and girls, with and without recent medication histories 
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Table 6. Varimax rotated factors matrix for parent-completed SNAP, DSM-IV emulation. a,b 
Eigenvalues 
Non-Rotated Variance Percentage 
Factor 
I 
7.536 
53.825 
II 
1.718 
12.269 
I. Inattention 
11. Difficulty concentrating on school work or other tasks 
requiring sustained attention 0.836 0.223 
12. Difficulty organizing work (not due to cognitive impairment) 0.828 0.085 
13. Often fails to finish things he or she starts 0.809 0.212 
14. Easily distracted 0.795 0.357 
15. Often doesn't seem to listen 0.748 0.382 
16. Needs a lot of supervision 0.735 0.289 
17. Often acts before thinking 0.598 0.497 
18. Difficulty sticking to a play activity 0.538 0.440 
II. Hyperactivity/iinpulsivity 
HI. Always on the go or acts as if "driven by a motor" 0.218 0.831 
H2. Difficulty staying seated 0.309 0.826 
H3. Excessive running or climbing 0.133 0.801 
H4. Difficulty sitting still or excessive fidgeting 0.319 0.800 
H5. Difficulty waiting for turn in games or group situations 0.352 0.672 
H6. Frequent calling out in class 0.194 0.638 
aAll items under Peer Interactions were excluded in factor analysis. 
bBased on entire sample: 649 boys and girls, with and without recent medication histories 
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Figure 1. Varimax rotated factor loading plot for parent-completed SNAP, 
DSM-IV emulation. Factor 1 corresponds to DSM-IV inattention and 
factor II corresponds to DSM-IV hyperactivity/impulsivity. Individual 
labels correspond to SNAP items as listed in Table 6. 
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Table 7. Varimax rotated factors matrix for teacher-completed SNAP, DSM-IV emulation. a,b 
Eigenvalues 
Non-Rotated Variance Percentage 
I 
1.780 
13.693 
Factor 
n 
7.492 
57.630 
I. Inattention 
11 Difficulty concentrating on school work or other tasks 
requiring sustained attention 0.879 0.253 
12. Often fails to finish things he or she starts 0.853 0.122 
13. Difficulty organizing work (not due to cognitive impairment 0.814 0.189 
14. Easily distracted 0.791 0.411 
15. Often doesn't seem to listen 0.776 0.323 
16. Needs a lot of supervision 0.707 0.428 
II. Hyperactivity/impulsivity 
HI. Always on the go or acts as if "driven by a motor" 0.220 0.831 
H2. Difficulty staying seated 0.375 0.781 
H3. Frequent calling out in class 0.219 0.774 
H4. Difficulty sitting still or excessive fidgeting 0.417 0.768 
H5. Motor restlessness 0.353 0.765 
H6. Excessive running or climbing 0.083 0.756 
H7. Difficulty waiting for turn in games or group situations 0.263 0.743 
aAll items under Peer Interactions were excluded in factor analysis. 
bBased on entire sample: 649 boys and girls, with and without recent medication histories. 
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Figure 2. Varimax rotated factor loading plot for teacher-completed 
SNAP, DSM-IV emulation. Factor I corresponds to DSM-IV inattention 
and factor II corresponds to DSM-IV hyperactivity/impulsivity. Individual 
labels correspond to SNAP items as listed in Table 7. 
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hyperactivity/impulsivity were created by averaging the item scores under the respective 
factors. Interestingly, the items under the DSM-IV inattention factor were identical to those 
under the DSM-III inattention/impulsivity factor for both parent-completed and teacher- 
completed SNAP. However, unlike the original factor analysis, several items under the 
standard SNAP Impulsivity category factored with items under the SNAP Hyperactivity 
category. 
4.2 Cross-Informant Correlations 
Pearson product-moment correlations between parent-rated factor scales and teacher¬ 
rated factor scales were weak. Correlations between pairs of parent-rated factor scales were 
moderately strong and correlations between pairs of teacher-rated factor scales were very 
strong. Mean correlation coefficients, calculated as the average of these pairwise 
correlations, showed similar trends across all four factor scales under study (Table 8). The 
high correlations between identical informants and the low correlations between different 
informants supported separate analyses of parent-rated and teacher-rated factor scales 
Clearly, parents and teachers rate children differently; combining data from these informants 
might obscure important perceptual or situational factors that influence their ratings. 
4.3 Bivariate Correlations 
There were no significant correlations between any factor scale and dopamine or 
cortisol excretion. For parent-rated scales, significant correlations were observed between 
several factor scales and urinary epinephrine levels (Table 9, Figures 3 through 6). The parent 

Table 8. Mean cross-informant Pearson product-moment correlations. 
DSM-III inattention/impulsivity DSM-III hyperactivity 
Parents Teachers Parents Teachers 
Parents 0.652 Parents 0.632 
Teachers 0.401 0.817 Teachers 0.354 0.834 
DSM-IV inattention DSM-IV hyperactivity/impulsivity 
Parents Teachers Parents Teachers 
Parents 0.675 Parents 0.722 
Teachers 0.416 0.817 Teachers 0.455 0.878 
'Based on partial sample: 251 boys, without recent medication histories. 
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Table 9. Correlations between urinary catecholamines and factor scales.3 
norepinephrine levels epinephrine levels 
factor scale correlation P correlation P 
Parent DSM-III emulation 
Composite inattention/impulsivity 
factor-analyzed SNAP inattention/impulsivity -0.125 0.049 
YCI attention/impulsivity 
DISC-2.3 inattention/impulsivity -0.155 0.014 
Composite hyperactivity 
factor-analyzed SNAP hyperactivity 
YCI activity 
DISC-2.3 hyperactivity 
Teacher DSM-III emulation 
Composite hyperactivity 
factor-analyzed SNAP hyperactivity 
MIT activity 
Parent DSM-IV emulation 
Composite inattention -0.145 0.022 
factor-analyzed SNAP inattention 
YCI attention 
-0.125 0.049 
DISC-2.3 inattention 
Composite hyperactivity/impulsivity 
-0.206 0.001 
factor-analyzed SNAP hyperactivity/impulsivity 
YCI activity/mipulsivity 
DISC-2.3 hyperactivity/impulsivity 
Teacher DSM-IV emulation 
Composite inattention -0.177 0.005 -0.213 0.001 
factor-analyzed SNAP inattention -0.150 0.018 -0.183 0.004 
MIT attention 
Composite hyperactivity/impulsivity 
-0.186 0.003 -0.222 0.000 
factor-analyzed SNAP hyperactivity/impulsivity 
MIT activity 
Tfon-sigmficant values have been suppressed in presentation. 
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parent factor-analyzed SNAP inattention 
or inattention/impulsivity (z score) 
Figure 3. Relationship between the teacher factor-analyzed SNAP scale 
for inattention or inattention/impulsivity and urinary epinephrine levels. 
Higher values on the abscissa are associated with more marked 
inattention. The parent factor-analyzed SNAP scale for inattention or 
inattention/impulsivity is significantly negatively correlated with 
epinephrine excretion (r=-0.125, p<0.049). 
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parent DISC-2.3 
inattention/impulsivity (z score) 
Figure 4. Relationship between the parent DISC-2.3 scale for 
inattention/impulsivity and urinary epinephrine levels. Higher values on 
the abscissa are associated with more marked inattention/impulsivity. The 
parent DISC-2.3 scale for inattention/impulsivity is significantly 
negatively correlated with epinephrine excretion (r=-0.155, p<0.014). 
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Figure 5. Relationship between the parent composite DSM-IV-based scale 
for inattention and urinary epinephrine levels. Higher values on the 
abscissa are associated with more marked inattention. The parent 
composite DSM-IV-based scale for inattention is significantly negatively 
correlated with epinephrine excretion (r=-0.145, p<0.022). 
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1400 
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parent DISC-2.3 inattention 
(z score) 
Figure 6. Relationship between the parent DISC-2.3 scale for inattention 
and urinary epinephrine levels. Higher values on the abscissa are 
associated with more marked inattention. The parent DISC-2.3 scale for 
inattention is significantly negatively correlated with epinephrine excretion 
(r=-0.206, p<0.001). 
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DSM-IV-based composite scale for inattention correlated negatively with urinary epinephrine 
levels (r = -0.145, p < 0.022) while the parent DSM-III-based composite scale for 
inattention/impulsivity did not correlate significantly with any of the measured urine 
catecholamines. For both of these composite scales, only two of their three component scales 
had significant negative correlations with epinephrine. Neither the YC1 scale for inattention 
nor the YCI scale for inattention/impulsivity were correlated significantly with catecholamine 
excretion. For teacher-rated scales, significant correlations were observed between several 
factor scales and urinary epinephrine and norepinephrine levels (Table 9, Figures 7 through 
12). The teacher DSM-IV-based composite scale for inattention correlated negatively with 
both urinary epinephrine (r = -0.213, p < 0.001) and urinary norepinephrine (r = -0.177, p < 
0.005) levels. Both of the component scales that constitute this composite scale also 
correlated negatively with both urinary epinephrine and urinary norepinephrine levels. In 
nearly ever/ case, the correlations between the teacher-rated factor scales and urinary 
epinephrine levels were stronger than the correlations between the parent-rated factor scales 
and urinary epinephrine levels. 
4.4 Multiple Regression Model 
In general, the multiple regression model reaffirmed the results from bivariate analysis 
(Table 10). When only the more significant correlations were examined (p < 0.015), none of 
the models were able to predict urinary dopamine and urinary cortisol levels. According to 
the linear model using the parent DSM-IV-based composite scales, inattention was a 
significant negative predictor of urinary epinephrine levels (beta = -0.201, p < 0.015) 
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Figure 7. Relationship between the teacher composite DSM-IV-based 
scale for inattention and urinary epinephrine levels. Higher values on the 
abscissa are associated with more marked inattention. The teacher 
composite DSM-IV-based scale for inattention is significantly negatively 
correlated with epinephrine excretion (r=-0.213, p<0.001). 
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teacher composite DSM-IV-based 
inattention (z score) 
Figure 8. Relationship between the teacher composite DSM-IV-based 
scale for inattention and urinary norepinephrine levels. Higher values on 
the abscissa are associated with more marked inattention. The teacher 
composite DSM-IV-based scale for inattention is significantly negatively 
correlated with norepinephrine excretion (r=-0.177, p<0.005). 
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Figure 9. Relationship between the teacher factor-analyzed SNAP scale 
for inattention and urinary epinephrine levels. Higher values on the 
abscissa are associated with more marked inattention. The teacher factor- 
analyzed SNAP scale for inattention is significantly negatively correlated 
with epinephrine excretion (r=-0.183, p<0.004). 
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teacher factor-analyzed SNAP 
inattention (z score) 
Figure 10. Relationship between the teacher factor-analyzed SNAP scale 
for inattention and urinary norepinephrine levels. Higher values on the 
abscissa are associated with more marked inattention. The teacher factor- 
analyzed SNAP scale for inattention is significantly negatively correlated 
with norepinephrine excretion (r=-0.150, p<0.018). 
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Figure 11. Relationship between the teacher MIT scale for attention and 
urinary epinephrine levels. Higher values on the abscissa are associated 
with more marked inattention. The teacher MIT scale for attention is 
significantly negatively correlated with epinephrine excretion (r=-0.222, 
p<0.000). 
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teacher MIT attention 
(z score) 
Figure 12. Relationship between the teacher MIT scale for attention and 
urinary norepinephrine levels. Higher values on the abscissa are 
associated with more marked inattention. The teacher MIT scale for 
attention is significantly negatively correlated with norepinephrine 
excretion (r=-0.186, p<0.003). 
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Table 10. Standard coefficients of multiple regression model /1 
factor scale 
norepinephrine levels epinephrine levels 
beta_p_beta_p 
Parent DSM-IV emulation 
Composite 
inattention 
hyperactivity/impulsivity 
inattention X hyperactivity/impulsivity 
Factor-analyzed SNAP 
inattention 
hyperactivity/impulsivity 
inattention X hyperactivity/impulsivity 
YCI 
attention 
activity/impulsivity 
attention X activity/impulsivity 
DISC-2.3 
inattention 
hyperactivity/impulsivity 
inattention X hyperactivity/impulsivity 
Teacher DSM-I V emulation 
Composite 
inattention 
hyperactivity/impulsivity 
inattention X hyperactivity/impulsivity 
Factor-analyzed SNAP 
inattention 
hyperactivity/impulsivity 
inattention X hyperactivity/impulsivity 
MIT 
attention 
activity 
attention X activity 
-0.201 0.015 
-0.206 0.012 
-0.232 0.003 
-0.268 0.001 -0.290 0.000 
-0.250 0.005 -0.273 0.002 
-0.256 0.001 -0.264 0.001 
aNon-significant values have been suppressed in presentation. 
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Separate analyses of the individual instruments showed that the factor-analyzed SNAP 
inattention scale (beta = -0.206, p < 0.012) and the DISC-2.3 inattention scale (beta = -0.232, 
p < 0.003) were significant negative predictors of urinary epinephrine levels. However, the 
multiple regression model based on the YCI did not yield significant predictors of urinary 
catecholamines. Furthermore, none of the parent DSM-III-based models were significant 
predictors of urinary catecholamines. According to the multiple regression model using the 
teacher DSM-IV-based composite scales, inattention was a significant negative predictor of 
urinary epinephrine (beta = -0.290, p < 0.000) and urinary norepinephrine (beta = -0.268, p 
< 0.001) levels. Separate analyses of the individual instruments showed that the factor- 
analyzed SNAP inattention scale and the MIT attention scale were significant negative 
predictors of urinary epinephrine and urinary norepinephrine levels. Furthermore, the 
standard coefficients in the prediction of urinary epinephrine levels of teacher-rated scales 
were all stronger than those of parent-rated scales. 
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Chapter 5 
Discussion 
Although several studies have analyzed the urinary catecholamine profiles of ADHD 
patients, it is recognized that current diagnostic criteria are an amalgamation of symptoms 
whose relation to each other is often ambiguous. This study examines the relationships 
between urinary catecholamines and specific dimensional behavior scales based on DSM-III 
and DSM-IV criteria for ADHD. By focusing on pure behavioral scales, much of the 
controversy concerning the precise definition of ADHD is circumvented. Instead, the core 
constructs that define the disorder are examined separately with respect to catecholamine 
excretion to evaluate current conceptualizations of ADHD. 
It is important to understand that the modest correlations described in this study are 
reflective of the vast diversity of biological function and the wide range of biological response 
to cognitive testing. Catecholamines excreted in the urine derive from disparate pools 
thoughout the sympathoadrenomedullary system and are called upon differentially according 
to the body’s needs. Fortunately, the sample in this study is an order of magnitude larger than 
most study cohorts to date. With such statistical power, even small effects can be asserted 
with confidence. Additionally, the open-ended sampling procedure used in this study 
mitigates against selection bias introduced with more restricted (e.g. clinic referred) 
populations. 
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Factor A nalysis 
Factor analysis of the SNAP yielded two factors which related to DSM criteria for 
ADHD. The two factors, termed inattention/cognitive-impulsivity and hyperactivity, resemble 
DSM-III behavioral constructs for ADD. Since the SNAP is a DSM-III-based instrument, 
it is not surprising that the standard SNAP impulsivity items tended to factor with inattention. 
A more directed factor analysis was required to isolate two factors, termed inattention and 
hyperactivity^ehavioral-impulsivity, that resemble DSM-IV behavioral constructs for ADHD. 
The two-factor solutions that emerged from both these analyses is consistent with a bi- 
dimensional conceptualization of ADHD. Although the hyperactivity factor and the 
hyperactivity/behavioral-impulsivity factor were different, the inattention/cognitive-impulsivity 
factor and the inattention factor were identical. Examination of the individual items revealed 
that this factor is somewhat of a compromise between DSM-III and DSM-IV; it contains 
fewer impulsivity items than the DSM-III inattention/impulsivity construct, yet more 
impulsivity items than the DSM-IV inattention construct. 
Cross-Informant Ratings 
The high correlations found between identical informant ratings and the low 
correlations found between different informant ratings is consistent with many other studies 
(Achenbach et al., 1987). In that meta-analysis, the authors found a 0.60 correlation between 
informants serving similar roles with regard to the proband and a 0.28 correlation between 
informants serving different roles with regard to the proband. These results pose a dilemma 
as to selecting the “best” informant, especially when responses are used to establish a 
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diagnosis of ADHD. Children’s behavior often varies, not only across situations, but even 
in the same situation at different times. These data reaffirm the need for researchers and 
clinicians to be aware of the nature of the disorder being assessed and the specificity of 
assessment instruments as rated by different informants. 
Bivariate Analysis 
Several categorical studies have reported reduced epinephrine excretion in ADHD 
patients compared to normal controls (Klinteberg et al., 1989; Pliszka et al1994; Hanna et 
a/., 1996). This study supports others which have found that reduced urinary epinephrine 
levels correlated specifically with the construct of inattention (Elwood et al., 1986; Rogeness 
et al., 1989). This relationship is robust given that it applied whether a dimensional or a 
categorical approach was used to characterize ADHD. However, reports that urinary 
epinephrine levels are also negatively correlated with hyperactivity were not supported 
(Johannson et al, 1973; Tennes et al., 1986; Rogeness et al., 1989). 
Correlations were generally stronger when children were rated by teachers than when 
they were rated by parents. Among the possible explanations for this result is that teachers 
may provide a more objective point of view than parents, who are often unaware of 
developmental or gender norms. Another consideration is that certain behaviors may be 
situationally specific. The stressful setting of the classroom, including continuous interaction 
with teachers and peers, places unusual demands upon children. It is usually not until children 
begin formal schooling that aberrant symptomatology becomes overt and ADHD is initially 
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diagnosed. The finding that teachers are accurate assessors of children’s behavior is 
consistent with previously reported findings (Gresham et cil., 1997). 
Interestingly, significant negative correlations were found between the DSM-IV-based 
inattention scales and urinary norepinephrine levels, but only for teacher-completed ratings. 
This result supports an earlier finding that urinary norepinephrine levels are negatively 
correlated with inattentiveness to school assignments (Tennes et a/., 1986). All correlations 
found for norepinephrine excretion were weaker than those for corresponding epinephrine 
excretion. The fact that both teacher and parent ratings revealed negative correlations with 
urinary epinephrine levels suggests that their perceptions may be grossly similar, in that both 
informants detect roughly the same children as having roughly the same level of impairment. 
The fact that only teacher ratings reveal additional negative correlations with urinary 
norepinephrine suggests that teachers may be more discriminating, whether because they are 
superior judges or because the classroom setting elicits certain behaviors that are not overt 
at home. As a result, their precise placement of children on the inattention continuum may 
be more accurate than parents’ placements. 
Alternatively, it is possible that the cognitive tests administered for this study are more 
similar to the types of challenges that a child may face in the classroom rather than at home. 
Then catecholamine excretion measured during the cognitive battery will naturally be more 
closely aligned with teacher ratings. If this artifact exists, then teachers and parents cannot 
be compared as described above. Rather, the researcher must be aware of the relation 
between the rater and the cognitive assessment methods administered during sample 
collection. Here, one might conclude that for this mixed battery of cognitive tests, teacher 
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ratings are more correlated with catecholamiiie excretion than parent ratings. In fact, it may 
not even be meaningful to correlate parent-based data with neurochemical data derived from 
this set of tests. Whether this relation will hold for another set of tests is indeterminate from 
this study. 
Multiple Regression Model 
Analysis using the multiple regression model mainly reaffirmed the results found with 
bivariate correlations. The parent DSM-IV-based scales of inattention that showed significant 
correlations in bivariate analysis were found to be significant negative predictors of urinary 
epinephrine levels. The teacher DSM-IV-based scales of inattention that showed significant 
correlations in bivariate analysis were found to be significant negative predictors of both 
urinary epinephrine and urinary norepinephrine levels. The multiple regression model has the 
advantage of taking into account multiple factors which may have an influence upon 
catecholamine excretion. Results indicate that factors relating to hyperactivity do not 
significantly influence the predictive ability of inattention, nor are there any significant 
interactions between the two scales. 
DSM-III vs. DSM-IV 
The DSM-IV-based scale for inattention can be compared with the DSM-III-based 
scale for inattention/impulsivity in several ways. The parent DSM-III-based composite scale 
for inattention/impulsivity did not correlate significantly with any catecholamine excretion 
However, the DISC-2.3 inattention/impulsivity subscale did correlate significantly (negatively) 
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with urinary epinephrine levels. But this correlation was weaker than the correlation attained 
with the DISC-2.3 inattention subscale that was used to create the parent DSM-IV-based 
scale for inattention. Another way to compare the DSM-III construct of 
inattention/impulsivity with the DSM-IV construct of inattention is to examine the separate 
subscales used to create the teacher DSM-IV-based composite scale for inattention. The 
MIT, which is a purer scale for inattention, revealed stronger correlations with both urinary 
epinephrine and norepinephrine levels than the SNAP, which includes some elements of 
impulsivity along with inattention. 
Still another way to compare these constructs is to note that the two DSM-III-based 
scales that showed significant correlations in bivariate analysis were not significant predictors 
in the multiple regression model. Yet, all the DSM-IV-based scales that showed significant 
correlations in bivariate analysis were significant predictors in the multiple regression model 
Taken together, these data indicate that the DSM-IV-based inattention scale correlates more 
strongly with neurochemical data than the DSM-III-based inattention/impulsivity scale 
Overall, this study attests to the construct validity of the DSM-IV characterization of ADHD 
which separates inattention and impulsivity. 
Future Directions 
In this study, only four behavioral constructs directly related to ADHD were 
considered. Further research is necessary to determine whether any other behavioral or 
cognitive measures are correlated with urinary catecholamine and urinary cortisol 
concentrations. As alluded to above, effort should also be invested in examining what effects 
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administering different sets of cognitive tests have on neurochemical correlations based on 
parent- versus teacher-rated instruments. It is possible that parent-rated instruments will yield 
higher correlations with tests that reflect the home environment. Given the complexity and 
variability of child psychopathology, future studies should also concentrate on the the 
disorders that are commonly comorbid with ADHD. There are suggestions that ADHD 
children with and without comorbid RD may be neurochemically distinct with respect to 
noradrenergic function (Halperin et a/., 1993; Halperin et al., 1997). Another study found 
that increased epinephrine excretion may distinguish ADHD children with comorbid anxiety 
from ADHD children without comorbid anxiety (Pliszka et al., 1994). 
Finally, it must be recognized that the interpretations presented here are merely 
speculative, given both the variability of the measurements and the uncertainty as to what 
processes are actually measured. The small correlations that were found in this study are 
certainly not diagnostic for ADHD. A more complete understanding of central and peripheral 
neurochemical mechamisms is necessary before any results pertaining to catecholamine 
measurements can be interpreted from a biological point of view. Results from this study will 
contribute to a better discretion of the disorder and guide more comprehensive explorations 
of the sympathoadrenomedullary system and its relation to behavior. 
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ABSTRACT 
Objective: Reported correlations between epinephrine (EPI) excretion and classroom performance, the cognition-enhancing 
effects of EPI infusion, increased EPI excretion with stimulants, and reports of decreased EPI excretion in attention-deficit/ 
hyperactivity disorder (ADHD) suggest that sympathoadrenomedullary function might be altered in ADHD. This hypothesis 
was tested by examining sympathetic and adrenomedullary functioning during cognitive testing in boys with diagnosed 
ADHD. Method: Urinary excretion of EPI and norepinephrine during a 3-hour cognitive test battery was assessed in 7- to 13- 
year-old boys. Excretion rates (nanograms per hour per square meter of body surface area) were determined in 200 individ¬ 
uals with ADHD (diagnosed according to DSM-IVcriteria), with or without co-occurring oppositional defiant/conduct disorder 
or learning disorder. A non-ADHD contrast group (n = 51) with similar comorbidity was also studied. Results: Substantially 
lower (mean ± SE) urinary EPI excretion was observed in the ADHD-inattentive subtype (n = 71) compared with the control 
group (200 ± 22 versus 278 ± 24 ng/hr/m2; F= 5.99, p= .015, critical a= .017). No diagnostic group differences were seen for 
norepinephrine excretion. Correlational analysis of both parent- and teacher-rated behaviors revealed that inattention fac¬ 
tors consistently negatively predicted urinary EPI excretion. Conclusions: The data extend findings of lower adrenome¬ 
dullary activity during cognitive challenge in individuals with ADHD and suggest that the alteration is associated with 
inattentive behavior. J. Am. Acad. Child Adolesc. Psychiatry, 2000, 39(5):635-643. Key Words: epinephrine, inattention, atten¬ 
tion-deficit/hyperactivity disorder. 
Arousal mechanisms may play an important part in the 
maladaptive behaviors included among the DSAf-IVdiag¬ 
nostic criteria for attention-deficit/hyperactivity disorder 
(ADHD). Regardless of the particular nosology used to 
describe and define children with difficulties in attending 
to schoolwork and adapting to the classroom, chere has 
been continuing interest in the possibility of altered 
arousal in such children (Bradley, 1937; Halperin et al., 
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1997; Hastings and Barkley, 1978; McMahon, 1984; 
Oades, 1987; Ornitz et al., 1997; Satterfield et al., 1974). 
The crucial role of the central noradrenergic system and 
sympathetic nervous system in regulating arousal, together 
with noradrenergic effects of sdmulant medication, has led 
to hypotheses of noradrenergic involvement in ADHD 
(Hunt et al., 1984; Mefford and Potter, 1989; Mikkelsen 
et al., 1981; Pliszka et al., 1996; Shekim et al., 1979; 
Snyder and Meyerhoff, 1973). To date, neurochemical 
studies have not provided convincing supporting evidence 
of alterations in norepinephrine (NE) (Ernst and Zametkin, 
1995; Raskin et al., 1984; Zametkin and Rapoport, 1987). 
However, treatment studies using noradrenergic-specific 
agents (Chappell et al., 1995; Cyr and Brown, 1998; Hunt 
et al., 1995), along with an increasing appreciation of the 
role of central NE in attention and cognition (Arnsten, 
1997; Arnsten et ah, 1996; Aston-Jones et ah, 1991; 
Williams and McGaugh, 1993), have served to maintain 
interest in central and peripheral NE. 
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The Epinephrine Hypothesis in ADHD 
An extensive line of research (Frankenhaeuser, 1971; von 
Euler, 1964) has firmly established a positive association 
between classroom performance and epinephrine (EPI) 
excretion. This work, along with reports of stimulant- 
induced EPI release and longstanding observations of 
cognition-enhancing effects of systemically administered 
EPI (Frankenhaeuser and Jarpe, 1963; Introini-Collision 
et al., 1992; Roozendaal et ah, 1996; Williams and 
McGaugh, 1993), suggests a possible role for EPI in 
ADHD. Two extensive reviews have focused on how al¬ 
terations in the regulation of the noradrenergic syscem 
might contribute to the pathophysiology of ADHD 
(Mefford and Potter, 1989; Pliszka et al., 1996). Mefford 
and Potter (1989) posited that reduced central EPI input 
to the noradrenergic locus ceruleus could lead to a dys- 
regulation of central NE and consequent disruption of 
attentional systems. In subsequent reviews by McCracken 
and colleagues (McCracken, 1991; Pliszka et al., 1996), 
the EPI hypochesis was broadened to include the possi¬ 
bility of alcered peripheral EPI (i.e., adrenomedullary) 
functioning. 
Previous Studies of Epinephrine in ADHD 
Studies examining urinary excretion of EPI and its 
metabolite, metanephrine, in ADHD are listed in Table 
1. Several points are noteworthy. First, the studies of base¬ 
line EPI excretion have not found differences between 
ADHD and control groups. Second, amphetamine and 
methylphenidate, the principal therapeutic agents used 
in ADHD, increase EPI excretion. However, relatively 
smaller adrenomedullary responses were seen in subjects 
with ADHD compared with controls after acute (Rapoport 
et al., 1978) or chronic (Donnelly et al., 1989; Elia et al., 
1990) administration of stimulant medication. Third, 2 
recent studies (Hanna et al., 1996; Pliszka et al., 1994) 
have found substantially lower rates of EPI excretion 
during cognitive testing in subjects with ADHD com¬ 
pared with normal controls (standardized effect sizes were 
1.2 and 0.73, respectively). This apparent diminished 
adrenomedullary activity during cognitive testing is con¬ 
sistent with prior studies correlating academic perfor¬ 
mance and EPI excredon (Frankenhaeuser, 1971). Finally, 
in a srudy examining plasma EPI, a blunted EPI response 
to the hypoglycemia occurring 3 to 4 hours after glucose 
TABLE 1 
Studies of Urinary Epinephrine Excretion in Attention-Deficit/Hyperactivity Disorder (ADHD) 
Study 
Subjects: 
ADHD/NC; 
Age Protocol Findings 
Baseline excretion 
Rapoport et al., 1970 19/6; 
5-10 yr 
24-hr coll. Normal EPI excretion in .ADHD 
Rapoport et al., 1978 15/14; 
9.4 ± 2.1 yr 
24-hr coll. Normal EPI excretion in ADHD 
Rogeness et al., 1989 50 inpatients; 
11.1 ± 2.7 yr 
24-hr coll. No correlation with ADHD symptoms in 
conduct disorder 
Effects of stimulants 
Rapoport et al., 1978 15/14; 
9.4 ± 2.1 yr 
24-hr coll., after acute PLBO 
or AMPH 
Lower EPI response to AMPH in ADHD (12% inc. 
vs. 100% inc. in NC) 
Shekim et al., 1979 23/13; 
7-12 yr 
24-hr coll., pre/post 2 wk AMPH Normal normetanephrine excretion in .ADHD; 
no change with drug 
Donnelly et al., 1989 20/0; 
6-12 yr 
24-hr coll., pre/post 3 wk PLBO 
or AMPH 
43% inc. on AMPH 
Elia et al., 1990 31/0; 24-hr coll, after 3 wk PLBO, -100% inc. in EPI excretion on drug; -30% inc. 
Effects of cognitive testing 
6-12 yr MPH. or AMPH in metanephrine on drug 
Pliszka et al., 1994 20/22: 
6-12 vr 
2-hr coll, during cognitive testing 45% lower EPI excretion in ADHD; normal rate in 
comorbid ADHD/anxiecy 
Hanna et al., 1996 12/16; 
7-11 yr 
80-min. coll, during cognitive testing 41% lower EPI excretion in ADHD 
Note: NC = normal controls; coll. = urine collection; PLBO = placebo; AiVIPH = amphetamine; MPH = methylphenidate: EPI = epinephrine; 
inc. = increase. 
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load was seen in ADHD subjects compared with controls 
(Girardi et al., 1995). The agreement across studies 
examining adrenomedullary function during various 
provocations, whether cognitive, pharmacological, or 
physiological, is remarkable. The daca are consistent in 
supporting the idea that EPI secretion during challenge 
is deficient in subjects with ADHD. 
Aims of This Study 
We have measured urinary EPI and NE excretion in 
large groups of ADHD subjects and non-ADHD contrast 
subjects to examine several closely related issues. A major 
aim was to replicate the basic finding of comparatively 
lower EPI excretion during cognitive testing, given the 
limited amount of data available in this area. We also 
wished to examine the specificity of the purported adre¬ 
nomedullary alteradon in terms of ADHD subtype and to 
study the effect of comorbid conditions, including opposi¬ 
tional defiant/conduct disorder (OD/CD) and learning 
disorder (LD), on EPI excretion. Finally, the possible pres¬ 
ence of an alteration in the closely related peripheral sym¬ 
pathetic nervous system was examined by also measuring 
urinary excretion of NE. The central effects of plasma EPI, 
the interaction of central and peripheral NE and EPI sys¬ 
tems, and the especially close linkage of central and 
peripheral NE have been noted. The involvement of these 
systems in arousal, attention, and cognition makes their 
study in ADHD of compelling interest. 
METHOD 
Diagnostic and Assessment Instruments 
Parents, usually the mother, completed the Swanson, Nolan, and 
Pelham Checklist (SNAP) (W.E. Pelham, M. Atkins, H. Murphy, J. 
Swanson, unpublished, 1984) and the Diagnostic Interview Schedule 
for Children Version 2.3 (DISC-2.3) (Shaffer et al., 1996). DISC-2.3 
modules completed included the behavioral disorders, depression, 
and anxiety modules. Classroom teachers completed the SNAP and 
the Multigrade Inventory for Teachers (MIT) (Agronin et al., 1992). 
Subject Recruitment and Screening 
Subjects were recruited over a 5-year period to participate in a large 
behavioral and cognitive assessment study at the Yale University 
Center for Learning and Attention. Boys having trouble paying atten¬ 
tion in school or with learning problems were sought by local media 
announcements or identified by schools, parent groups, and profes¬ 
sionals. Boys without evident artentional or learning problems were 
recruited over the same period by means of newspaper advertise¬ 
ments, letters to schools, and fliers in toy stores and libraries. An ini¬ 
tial telephone screen provisionally established that all subjects satisfied 
the following criteria: (1) between 7.0 and 13.5 years old; (2) no pre¬ 
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viously assigned diagnosis or indication of psychiatric (other than LD, 
ADHD, or other disruptive behavior disorder) or neurological dis- 
' order, as ascertained by parental report; (3) not mentally retarded; (4) 
English as their primary language; and (5) normal or corrected vision 
and hearing. Subjects in need of acute clinical care or support were 
excluded and referred to appropriate care providers. Approximately 
20% of individuals who contacted the Center were excluded for one 
or more of the above-listed criteria. A total of 380 boys entered the 
protocol and received an extensive neuropsychiatric assessment. 
Subjects 
Boys who entered the protocol were selected to participate in the 
study of urinary catecholamine excretion if they met the following 
additional criteria: (1) no siblings in the sample, (2) either no history 
of stimulant medications or abstinent from stimulant medications 
for at least 1 month before testing, and (3) Full Scale IQ score greater 
than or equal to 80 on the WISC-R (Wechslcr, 1974). Of the 251 
subjects selected for participation, 200 met DlSC-2.3-derived DSAI- 
IVcriteria for ADHD (American Psychiatric .Association, 1994; 
ShafFer et al., 1996). Subjects were also characterized according to 
ADHD subtype: inattentive type (n = 71), hyperactive-impulsive type 
(n = 26), and combined type (n = 103). Comorbid OD/CD was diag¬ 
nosed according to DSM-IVcriteria; comorbid LD (including both 
reading and math disorder) was diagnosed when age-standardized 
scores on the relevant tests of the Woodcock-Johnson Psvchoeduca- 
tional Battery were either at least 1.5 standard errors of prediction 
below that predicted by the subject's Full Scale W1SC-R IQ score or 
below the 25th percentile. Extensive comorbid OD/CD (rt = 37. 
19%), LD (/t = 48, 24%), and combined OD/CD»LD (n = 45, 
23%) were present in the .ADHD group. In the 5 l subjects not meet¬ 
ing criteria for ADHD (the "non-ADHD contrast" group, n = 51). 
comorbid OD/CD, LD. and OD/CD + LD was present in 8 (16%). 
26 (53%). and 5 (10%) of the subjects, respectively. Only 12 (24%) 
of the non-ADHD contrast group and 70 (35%) of the .ADHD sub¬ 
jects were without any other psychiatric diagnosis. The high rates of 
comorbid LD and OD/CD are expected given the nature of the 
recruitment and screening processes. The absence of depression or 
anxiety (as ascertained by the DISC) in both the ADHD and contrast 
groups was not unexpected given the initial screening that took place. 
It should be emphasized that subjects were assigned to the ADHD 
group or the non-ADHD contrast group irrespective of whether they 
had been initially recruited as having artentional problems or as being 
without evident attcntional difficulties. Given the nature of the 
recruitment, the groups can be assumed to be more representative 
than the usual clinic-based sample (Cohen and Cohen, 1984). Mean 
ages (iSE) in the non-ADHD contrast group and the 3 .ADHD sub- 
types (inattentive, hyperactive-impulsive, and combined) were 9.8 t 
0.2, 10.2 ± 0.2, 9.3 t 0.3, and 10.0 ± 0.2 vears, respectively. 
Cognitive Testing 
The evaluation consisted of four 4-hour sessions, each running 
from 8:30 a.M. to 12:30 P.M. over 4 days. The first session was a 
screening session in which subjects underwent ability and achieve¬ 
ment testing. During the second and third sessions, subjects were 
given a varierv of attention, language, visual motor, visual perception, 
and neuromaturation tests. Tests administered during the second ses¬ 
sion included measures of finger dexterity, visual motor integration, 
visual search, figure matching task, embedded figure identification, 
silent reading comprehension, auditor/ word string recall, continuous 
performance, and divided attention. On the fourth visit an EEG and 
the Posner task were administered. 
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Urine Collection 
Urine samples were collected over a rimed 3-hour period (9:30- 
12:30) during the second session of resting. Subjects were instructed 
to void to begin the timed collection and were encouraged to drink 
several glasses of water or apple juice during the testing period. Total 
urine volume was measured, and a 5-mL portion was placed in a stor¬ 
age vial containing preservatives and stored at -70°C (see Anderson 
ct ah, 1988). Mean urine collection volumes in the ADHD and non- 
ADHD groups were similar (253 ± 206 versus 267 ± 223 mL). 
Neurochemical Analysis 
Urinary catecholamine (EPI and NE) concentrations (nano- 
grams per milliliter) were measured using high performance liquid 
chromatography-fluorometry (Anderson et ah, 1988). Observed 
excretion rates (nanograms per hour) were expressed as nanograms 
per hour per square meter of body surface area (ng/hr/nrr) using 
Mosteller's equation. 
Statistical Analyses 
Categorical Comparisons. To examine the effects of OD/CD, LD. 
ADHD, and ADHD subtype status on urinary catecholamine excre¬ 
tion, and due to the correlation (r = 0.52, p < .001) seen between NE 
and EPI excretion rates, a 3-way multivariate analysis of variance 
(MANOVA) was performed with NE and EPI excretion as the 2 
dependent measures. The 3 (actors of ADHD, OD/CD, and LD were 
included with 4, 2, and 2 levels, respectively. As only a weak correlation 
was observed between EPI excretion and age (r = -0.13,/> = .038), age 
was noc included as a covariate. A series of 3 univariate planned pair¬ 
wise comparisons was then performed, comparing EPI excretion in 
each of the ADHD subtypes with that in the non-ADHD group. 
Correlational Analyses. Pearson product-moment correlations were 
calculated to examine relationships between each of the factor scales 
(inattention and hyperactivity-impulsivity) and urinary catecholamine 
excretion rates. Additional analyses were performed using a linear mul¬ 
tiple regression model to determine the extent to which the factor 
scales predicted urinary catecholamine excretion. Following DSM-IV 
criteria, terms for the linear model were inattention, hyperactivity- 
impulsivity, and their interaction. 
Calculation of Factor Scales and Composites. A factor scale, defined 
as the average of a factors constituent item scores, was calculated for 
the inattention and hyperactivity-impulsivity domains. Items from 
the MIT and DISC-2.3 were used as defined. The SNAP was factor- 
analyzed using DSM-IV-consistent subtypes; details of the principal 
component analysis are available upon request. All factor scales were 
standardized (to a mean of 0 and an SD of 1) to facilitate comparison 
between individual instruments. In addition to the factor scales deter¬ 
mined for each of the instruments, parent-rated and teacher-rated 
composite scales for inattention and for hyperactivity-impulsivity 
were created. Composite scales were constructed by averaging across 
the instruments the standardized factor scale scores relevant to the 
domain in question. Pearson product-moment correlations were used 
to examine relationships among the composite and individual factor 
scales when parents and teachers served as informants. The teacher¬ 
rated MIT and SNAP factor scores within each behavioral domain 
were highly correlated (MIT versus SNAP inattention, r= 0.817,/ < 
.0001; MIT versus SNAP hyperactivity-impulsivity, r = 0.834, p < 
.OOOlJ.'while the 2 parent-rated instruments were somewhat less 
highly correlated (SNAP versus DISC inattention, r = 0.660, p < 
.0001; SNAP versus DISC hyperactivity-impulsivity, r = 0.644, p < 
.0001). In contrast, lower correlations were seen when the parent- and 
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teacher-rated SNAP factor scores were compared (parent- versus 
teacher-rated SNAP inattention, r = 0.450. /> < .0001; parent- versus 
teacher-rated SNAP hyperactivity-impulsivity, r = 0.377, p < .0001). 
The high correlations seen across the teacher-rated instruments serve 
to support the use of the composite scales; this was less so with respect 
to combining the parent-rated instruments. 
RESULTS 
Diagnostic Group Comparisons 
For che 3-way MANOVA, the main effects of OD/CD 
and LD scacus on EPI and on NE excretion were noc sig¬ 
nificant, nor were significant 2-way or 3-way interactions 
observed between OD/CD, LD, and ADHD status (allp 
values >.23). The groups were thus collapsed across the 
OD/CD and LD diagnoses, leaving the ADHD group 
and non-ADHD contrast group. Differences between che 
3 ADHD subtypes and che non-ADHD contrast group 
were then examined in a series of 3 planned univariace 
comparisons (Bonferroni correction giving a critical a value 
of .0167). As seen in Figure 1, subscandaily lower urinary 
EPI excretion was observed in the ADHD-inatcencive 
subtype (200 ± 186 ng/hr/m2; mean ± SD) compared 
wich che non-ADHD contrast group (278 ± 173 ng/ 
hr/m2; F = 5.66, p = .015). A standardized effect size of 
0.43 was calculated for the inattentive versus concrasc 
group comparison (medium effect size). The difference 
in EPI excretion between che ADHD-combined type 
(221 ± 151 ng/hr/m2) and the contrast group approached 
significance {F = 4.19,/) = .042), whereas excretion in the 
ADHD-hyperactive-impulsive group (264 ± 158 ng/ 
hr/m2) was similar to chac seen in the concrasc group {F = 
0.28, p = .59). Urinary NE excretion in che ADHD sub¬ 
groups (inattentive, combined, hyperactive-impulsive) 
did noc differ significandy from that in the contrast group 
(870 ± 541, 960 ± 440, and 987 ± 459, versus 1,060 ± 
500 ng/hr/m2, respectively). 
Bivariate Correlations 
For parenc-raced scales, significant correlations were 
consistendy observed between inattention factor scales 
and urinary EPI excretion (Table 2). The parental com¬ 
posite (SNAP+DISC) scale for inaccencion correlated 
negatively wich urinary EPI excretion (r = -0.145. p < 
.022). The separate parent-rated SNAP and DISC scales 
for inaccencion were also correlated significandy with 
EPI excrecion. No significant correlations were seen 
between catecholamine (EPI or NE) excretion and any of 
the parenc-rated hyperactivicy-impulsivity scales, or 
between NE excrecion and any of che parent-raced scales. 
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CONTRAST ADHD SUBTYPES 
GROUP 
Fig-1 Urinary epinephrine excretion in a non-ADHD concrasc group and in DSM-FVADHD subgroups during 
a 3-hour cognitive testing period. Excretion rates (mean t SE. nanograms per hour per square meter of body surface 
area) in the contrast group and the .ADHD inattentive, combined, and hyperactive-impulsive subgroups were 273 
t 24. 200 t 22. 221 t 15. and 264 t 31. respectively. The difference berween the contrast group and the inattentive 
group was significant (F= 5.66,/> = .015). ADHD = attention-deficit/hyperactivity disorder. 
TABLE 2 
Bivariate Correlational Analyses: 
Behavioral Scales Versus Catecholamine Excretion 
Epinephrine 
Excretion 
Norepinephrine 
Excretion 
r (/>) r (.P) 
Parent-derived scales 
COMPJ inattcncion 
-0.145 (-022) -0.040 (.530) 
COMP- HI 0.016 (.800) -0.014 (.820) 
SNAP inartencion 
-0.125 (.049) -0.023 (.715) 
SNAP HI -0.018 (.784) 0.022 (.733) 
DISC inattention -0.206 (.001) -0.064 (.316) 
DISC HI -0.050 (.428) -0.023 (.712) 
Teacher-derived scales 
COMP4 inattcncion -0.213 (.001) -0.177 (.005) 
COMP* HI 0.068 (.382) -0.031 (.625) 
SNAP inartencion -0.183 (.004) -0.150 (.018) 
SNAP HI -0.042 (.512) 0.039 (.533) 
MIT inattention -0.224 (.0004) -0.187 (.003) 
MIT HI -0.097 (.127) 0.045 (.481) 
Note: COMP = composite; HI = hyperactivity-impulsivity, SNAP = 
Swanson. Nolan, and Pelham Checklist; DISC = Diagnostic Interview 
Schedule for Children Version 2.3; MIT = Multigrade Inventory for 
Teachers. 
J Composite SNAP+DISC score. 
* Composite SNAP+MIT score. 
For teacher-raced scales, significant correlations were 
observed between inattention factor scales and both uri¬ 
nary EPI and NE excredon rates (Table 2). The teacher 
composite (SNAP+MIT) scale for inartencion correlated 
negatively with both urinary EPI (r = -0.213, p < .001) 
and urinary NE (r = -0.177, p < .005) levels. As seen in 
Figure 2, each of the component scales of this composite 
scale significandy and negadvely correlated with urinary 
EPI excretion. The correlations observed beeween uri¬ 
nary EPI and the teacher-raced factor scales were consis¬ 
tently stronger than che correlations obtained using the 
parent-rated factor scales; associations seen for EPI were 
invariably stronger chan those seen for NE (Table 2). No 
significant associations were seen with either EPI or NE 
excretion and the various (parent- and teacher-rated) 
hyperactivicy-impulsivicv scales. 
Multiple Regression Analyses 
Mulciple linear regression analysis produced a pattern 
of associadons very similar to that seen for the bivariace 
analyses. Regression using 3 predictors (inattention, 
hyperactivicy-impulsivity, and their interaction) of uri¬ 
nary catecholamine excrecion yielded multiple R values 
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TEACHER-RATED SNAP INATTENTION 
(z score) 
TEACHER-RATED MIT INATTENTION 
(z score) 
Fig. 2 Top portion depicts the relationship between teacher-rated SNAP 
scale for inattention and urinary epinephrine excretion. Higher values on the 
standardized SNAP scale indicate greater inattention. The inattention scale 
scores were significantly (negatively) correlated with epinephrine excretion 
(r =» -0.183. p » .004). Bottom portion depicts the relationship between 
teacher-rated MIT scale for inattention and urinary epinephrine excretion. 
Higher values on the standardized MIT scale indicate greater inattention. The 
inattention scale scores were significantly (negatively) correlated with epi¬ 
nephrine excretion (r a -0.224. p a .0004). SNAP a Swanson. Nolan, and 
Pelham Checklist: MIT a Multigrade Inventory for Teachers. 
only slightly (typically +0.03) and not significandy differ¬ 
ent from the corresponding bivariate correlation calcu¬ 
lated for the various measures of inattention and urinary 
EPI or NE. As was the case with the bivariate analyses, 
the multiple R values determined for the prediction of 
urinary EPI levels based on teacher-rated inattention 
scales were all stronger than those based on parent-rated 
scales; in addition, the associations between inattention 
and EPI excretion were consistently higher than those 
seen for NE excretion. 
DISCUSSION 
In this large study of urinary EPI and NE excretion 
during cognitive testing of 251 boys aged 7 to 13 years, 
lower rates of EPI excretion were observed in individuals 
with ADHD-inattentive subtype. No influence of comor- 
bid LD or OD/CD was observed. Although EPI and NE 
excretion rates were correlated, a trend toward decreased 
NE excretion in the ADHD-inattentive group did not 
obtain statistical significance. In bivariate correlational 
analyses and multiple regression analyses using parent and 
teacher ratings of attention, we found additional support 
for this inverse association between inattention and EPI 
excretion. The results are consistent with 2 smaller studies 
finding reduced EPI excreuon during cognitive challenge 
in subjects with ADHD (Hanna et al., 1996; Pliszka et al., 
1994). Our results extend these reports in indicating that 
the alteration is specifically associated with inattenuon. 
The finding of lower EPI excretion and presumed 
lower adrenomedullary functioning during cognitive test¬ 
ing in children with attention problems is consistent with 
previous studies showing a positive correlation between 
EPI excretion and classroom performance or adaptation 
(Elwood et al., 1986; Johansson et al., 1973; Lambert 
et al., 1969; Tennes et al., 1986). Taken together with the 
previous research, our results support the hypothesis that 
adrenomedullary function is altered in the inattentive and 
combined-type subgroups of ADHD subjects. More 
speculatively, the hypothesis can be stated as follows: 
Reduced adrenomedullary response to cognitive challenge 
contributes to the inattention seen in children with diag¬ 
nosed ADHD. Given the effects of EPI on central and 
peripheral arousal (particularly its effects in increasing 
blood glucose level and brain blood flow), decreased adre¬ 
nomedullary activity is congruent with the idea that 
hypoarousal may contribute to the inattention domain in 
ADHD. However, one cannot dismiss the possibility that 
the observed lower adrenomedullary output is a con¬ 
sequence, rather than a cause, of reduced attention or cog¬ 
nitive performance. 
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Several methodological issues deserve comment. First, 
the relatively low correlations observed when parent- and 
teacher-rated versions of the SNAP were compared are con¬ 
sistent with previous reports (Barkley et al., 1990) and are 
not surprising given the importance of setting on the rel¬ 
evant behaviors. Correlations observed between catechola¬ 
mine excretion and the teacher-rated scales were higher 
than those seen with parent-rated scales; this is also not sur¬ 
prising because the testing situation much more closely 
resembled the classroom than the home environment. 
The significant group difference observed for EP1 
excretion in the ADHD-inattentive group, and the more 
robust associations seen between inattention scales and 
EPI excretion compared with those seen for NE excretion, 
serve to focus interest on adrenomedullary function rather 
than the noradrenergic/sympathetic system. It should also 
be noted that the determination of urinary EPI output 
provides an excellent index of adrenomedullary secretion 
of EPI, as all other sources of EPI are insignificant (see 
Frankenhaeuser, 1971). Unlike many neurochemical 
measures, one does not have to make assumptions about 
urinary EPI regarding relative peripheral and central con¬ 
tributions; it is clear that the measure is in no way meant 
to be taken as a reflection of central EPI release. 
The inverse associations between inattention and uri¬ 
nary NE, seen here and in previous studies (Elwood et al., 
1986; Tennes et al., 1986), do suggest that alterations in 
sympathetic function may also be associated with atten¬ 
tion deficits. However, the more diverse and less well- 
defined physiological origins of urinary NE, along with 
the slighdy less robust nature of the NE findings, make 
this area somewhat less compelling. In addition, some of 
the positive correlations seen for the 2 catecholamines 
and, hence, a small proportion of the NE-behavioral 
associations may be due to the corelease from the adrenal 
of small amounts of NE along with EPI (Edwards and 
Jones, 1993). The reported enhancing effects of EPI on 
sympathedc activity (Moleman et al., 1992) also may have 
contributed to correlations between the 2 catecholamines. 
Future research on adrenomedullary functioning in 
ADHD should be concerned with further replication 
and more complete characterization of the basic finding. 
For instance, it unknown whether other challenges such 
as physical exercise, cold-pressor test, caffeine or nicotine 
administration, and emotional stress also elicit smaller 
EPI responses in children with ADHD or attentional 
problems, compared with control children. The study 
group was composed of 7- to 13-year-old boys; it is not 
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known whether a similar altered response is present in 
females or in younger children, adolescents, or adults 
with like diagnoses or deficits. In addition, while reduced 
group mean adrenomedullary functioning appears to be 
present in children with ADHD during either cognitive, 
hypoglycemic, or stimulant challenge, it is not clear 
whether the reductions seen across provocations have a 
common etiology. The relationship of the apparent 
diminished EPI release seen in ADHD to the reduction 
reported in familial alcoholism is also unclear (Swartz 
et al., 1987). Finally, there are a number of related ques¬ 
tions to be considered; How might the cognitive effects 
of EPI be mediated? What are the genetic and neurobio- 
logical bases of the reduced excretion? Might central EPI 
functioning also be altered? 
Limitations of the Study 
First, it should be noted that it is possible that the 
ADHD-inattentive group had a normal EPI increase 
with testing and that the observed lower group mean 
excretion during testing was a reflection of lower baseline 
excretion in that group. Although we are unable to rule 
out this possibility, previous reports are consistent in 
finding normal baseline excretion of EPI in subjects with 
ADHD (Table 1). Second, it may be fruitful to perform 
behavioral assessments during the challenge and urine 
collection period; the observed associations between bio¬ 
logical and behavioral measures might have been weak¬ 
ened due to the noncontemporaneous approach that was 
used. Finally, the combining of the ODD and the CD 
(which includes more aggressive subjects) diagnoses to 
form the OD/CD group may have obscured findings 
with respect to NE, as differences in NE measures have 
been reported in aggression. 
Clinical Implications 
It appears that individuals with ADHD-inattentive 
type have reduced adrenomedullary acdvity during cog¬ 
nitive challenge and thac the lower activity is associated 
with inattention. It can be tentatively suggested that def¬ 
icits in adrenomedullary functioning may contribute to 
the inattention seen in individuals with ADHD. The 
data presented here, taken along with prior studies and 
the demonstrated effects of EPI on the brain and relevant 
behaviors, prompt us to speculate that differences in 
adrenomedullary functioning may be important deter¬ 
minants of a major domain of ADHD-related behavior. 
The restriction of the EPI findings to the inattention 
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domain tends to support the D5A/-/VconceptuaJization 
of the components of ADHD-related behavior (Lahey * 
et al., 1994). Recent family-based genetic studies have 
also provided evidence that the DSM-IV-delineated 
domains of ADHD-related behavior are differentially 
affected or influenced by specific genetic determinants 
(Rowe et al., 1998; Waldman et al., 1998). Measurement 
of EPI excretion during cognitive challenge may provide 
a route to assessing ADHD subtype, to predicting drug 
response, and to assessing affects of drug treatment. In 
addition, and as has been suggested by Pliszka et al. 
(1996) and Keith McBurnett (personal communication, 
1998), the findings lend support to the idea chat periph¬ 
erally acting adrenaline analogs may be useful in treating 
ADHD-associated inattention. Further research is needed 
to determine the causes and consequences of the finding 
and to explore the possibility that adrenomedullary func¬ 
tioning may play an important role in the inattention 
component of ADHD-related behavior. 
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